[go: up one dir, main page]

EE04577B1 - Sferoidi südamik ja selle valmistamismeetod, sferoid ja kapseldatud, pikendatud toimeajaga ravimvorm - Google Patents

Sferoidi südamik ja selle valmistamismeetod, sferoid ja kapseldatud, pikendatud toimeajaga ravimvorm

Info

Publication number
EE04577B1
EE04577B1 EEP200000212A EEP200000212A EE04577B1 EE 04577 B1 EE04577 B1 EE 04577B1 EE P200000212 A EEP200000212 A EE P200000212A EE P200000212 A EEP200000212 A EE P200000212A EE 04577 B1 EE04577 B1 EE 04577B1
Authority
EE
Estonia
Prior art keywords
spheroid
preparation
dosage form
extended release
release dosage
Prior art date
Application number
EEP200000212A
Other languages
English (en)
Estonian (et)
Inventor
Marie Sherman Deborah
Clifton Clark John
Ulrick Lamer John
Andrew White Stephen
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25508423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04577(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of EE200000212A publication Critical patent/EE200000212A/xx
Publication of EE04577B1 publication Critical patent/EE04577B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200000212A 1997-11-05 1998-11-03 Sferoidi südamik ja selle valmistamismeetod, sferoid ja kapseldatud, pikendatud toimeajaga ravimvorm EE04577B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96432897A 1997-11-05 1997-11-05
PCT/US1998/023338 WO1999022724A2 (en) 1997-11-05 1998-11-03 Extended release formulation containing venlafaxin

Publications (2)

Publication Number Publication Date
EE200000212A EE200000212A (et) 2001-04-16
EE04577B1 true EE04577B1 (et) 2006-02-15

Family

ID=25508423

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000212A EE04577B1 (et) 1997-11-05 1998-11-03 Sferoidi südamik ja selle valmistamismeetod, sferoid ja kapseldatud, pikendatud toimeajaga ravimvorm

Country Status (39)

Country Link
EP (1) EP1028718B1 (xx)
JP (1) JP2001521892A (xx)
KR (1) KR20010031797A (xx)
CN (1) CN1278165A (xx)
AR (1) AR014012A1 (xx)
AT (1) ATE237320T1 (xx)
AU (1) AU747978B2 (xx)
BG (1) BG104397A (xx)
BR (1) BR9813179A (xx)
CA (1) CA2305242A1 (xx)
CL (1) CL2004001705A1 (xx)
CO (1) CO5011060A1 (xx)
CZ (1) CZ20001659A3 (xx)
DE (1) DE69813602T2 (xx)
DK (1) DK1028718T3 (xx)
EA (1) EA200000487A1 (xx)
EE (1) EE04577B1 (xx)
ES (1) ES2196620T3 (xx)
GE (1) GEP20043198B (xx)
HK (1) HK1029056A1 (xx)
HR (1) HRP20000213B1 (xx)
HU (1) HU225238B1 (xx)
ID (1) ID26317A (xx)
IL (1) IL135457A0 (xx)
MA (1) MA24691A1 (xx)
NO (1) NO20002126L (xx)
NZ (1) NZ504460A (xx)
PA (1) PA8462501A1 (xx)
PE (1) PE128699A1 (xx)
PL (1) PL341141A1 (xx)
PT (1) PT1028718E (xx)
SK (1) SK6472000A3 (xx)
SV (1) SV1998000131A (xx)
TR (1) TR200001232T2 (xx)
TW (1) TW555568B (xx)
UA (1) UA77145C2 (xx)
UY (2) UY25234A1 (xx)
WO (1) WO1999022724A2 (xx)
ZA (1) ZA9810081B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1905757A1 (en) * 1999-04-06 2008-04-02 Sepracor Inc. Derivatives of Venlafaxine and methods of preparing and using the same
JP2003500348A (ja) * 1999-05-20 2003-01-07 エラン コーポレーシヨン ピーエルシー 多粒子状制御放出選択的セロトニン再吸収阻害剤製剤
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
WO2003050075A1 (en) * 2001-12-05 2003-06-19 Wyeth Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
AU2002247945A1 (en) * 2001-12-13 2003-06-23 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
AU2003221535A1 (en) 2002-03-28 2003-10-13 Synthon B.V. Venlafaxine besylate
AU2003226751A1 (en) 2002-03-28 2003-10-13 Synthon B.V. Low water-soluble venlafaxine salts
WO2003082262A2 (en) * 2002-03-28 2003-10-09 Synthon B.V. Compositions of venlafaxine base
WO2003082261A1 (en) * 2002-03-28 2003-10-09 Synthon B.V. Extended release venlafaxine formulations
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
CA2415154C (en) * 2002-12-24 2009-06-16 Biovail Laboratories Inc. Modified release formulations of selective serotonin re-uptake inhibitors
DE10350194B4 (de) * 2003-10-28 2005-11-10 Bioplanta Arzneimittel Gmbh Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
TW200503670A (en) * 2003-03-28 2005-02-01 Sandoz Ag Venlafaxine compositions
PT1502587E (pt) * 2003-07-30 2007-01-31 Pharmathen Sa Formulação de libertação prolongada para cloridrato de venlafaxina
HUP0303382A2 (hu) * 2003-10-10 2005-08-29 EGIS Gyógyszergyár Rt. Venlafaxin-hidroklorid-tartalmú pelletek
PT1711169E (pt) 2004-02-04 2007-07-23 Alembic Ltd Minicomprimidos revestidos de libertação prolongada de cloridrato de venlafaxina.
US7776358B2 (en) 2004-07-22 2010-08-17 Synthon Ip Inc. Extended release venlafaxine besylate tablets
CN101453996B (zh) * 2006-04-03 2016-05-11 伊萨·奥迪迪 药物递送组合物
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
CN102772390B (zh) * 2012-08-16 2014-01-08 乐普药业股份有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
FR3080278B1 (fr) * 2018-04-11 2021-04-30 Ghs Patents Ltd Procede de fabrication d'un spheroide de cannabidiol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
GEP20043198B (en) 2004-03-25
PE128699A1 (es) 2000-01-06
DK1028718T3 (da) 2003-07-28
HUP0004287A2 (hu) 2002-04-29
DE69813602T2 (de) 2003-11-06
HUP0004287A3 (en) 2002-05-28
BR9813179A (pt) 2000-08-22
AR014012A1 (es) 2001-01-31
NZ504460A (en) 2003-01-31
UA77145C2 (en) 2006-11-15
EE200000212A (et) 2001-04-16
AU1300399A (en) 1999-05-24
NO20002126L (no) 2000-05-04
HK1029056A1 (en) 2001-03-23
HRP20000213A2 (en) 2000-12-31
HRP20000213B1 (en) 2004-04-30
NO20002126D0 (no) 2000-04-26
UY25692A1 (es) 2000-03-31
EA200000487A1 (ru) 2000-10-30
CA2305242A1 (en) 1999-05-14
AU747978B2 (en) 2002-05-30
DE69813602D1 (de) 2003-05-22
ID26317A (id) 2000-12-14
PL341141A1 (en) 2001-03-26
CN1278165A (zh) 2000-12-27
EP1028718A2 (en) 2000-08-23
HU225238B1 (en) 2006-08-28
IL135457A0 (en) 2001-05-20
MA24691A1 (fr) 1999-07-01
CO5011060A1 (es) 2001-02-28
SV1998000131A (es) 1999-11-18
ZA9810081B (en) 2000-05-04
PT1028718E (pt) 2003-07-31
TR200001232T2 (tr) 2000-12-21
CL2004001705A1 (es) 2005-06-03
WO1999022724A2 (en) 1999-05-14
UY25234A1 (es) 2000-12-29
PA8462501A1 (es) 2000-05-24
KR20010031797A (ko) 2001-04-16
ATE237320T1 (de) 2003-05-15
WO1999022724A3 (en) 1999-07-22
SK6472000A3 (en) 2000-11-07
JP2001521892A (ja) 2001-11-13
TW555568B (en) 2003-10-01
BG104397A (en) 2001-02-28
ES2196620T3 (es) 2003-12-16
CZ20001659A3 (cs) 2001-10-17
EP1028718B1 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
EE04577B1 (et) Sferoidi südamik ja selle valmistamismeetod, sferoid ja kapseldatud, pikendatud toimeajaga ravimvorm
EE03676B1 (et) Mullpakend, selle valmistamise meetod ja mullpakendi kasutamine
EE04417B1 (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm, selle valmistamise meetod ja kasutamine
EE9700328A (et) Tahke oraalne preparaat, mis sisaldab toimeainena olansapiini, selle valmistamismeetod ja kasutamine
EE9800180A (et) Gonadotropiini riliisinghormooni antagonist, selle kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
EE9800181A (et) Gonadotropiini riliisinghormooni antagonist, selle kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
NO20001612L (no) Oralt preparat
IL129242A0 (en) Taste-masked microcapsule compositions and methods of manufacture
EE200300207A (et) Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
EE200100009A (et) Bensimidasoolid, nende valmistamine ja kasutamineravimitena
EE04490B1 (et) Ühend, selle valmistamise meetod ning kasutamine meditsiinis
EE200000621A (et) Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine
EE200100653A (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
EE200200105A (et) Radiofarmatseutilised saadused ja nende valmistamise meetod
EE04768B1 (et) Esmapakend ja meetod selle valmistamiseks
DE60019960D1 (de) Herstellung von isobutencopolymere
ATE355062T1 (de) Retard-zubereitungen von chinolon-antibiotika und verfahren zu ihrer herstellung
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EE200300153A (et) Östrogeeni retseptori modulaatorid, farmatseutiline kompositsioon ja selle valmistamismeetod
FI960507A0 (fi) Uudelleendispergoituvia, jauhemaisia ydinkuoripolymeerejä, niiden valmistus ja käyttö
EE200000099A (et) Antimükootiline kompositsioon, selle kasutamine ja valmistamismeetod ning antimükootiline toode
EE04770B1 (et) Tritsüklilised delta3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
DE59901361D1 (de) Präparationsmittel
EE9800075A (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
EE04260B1 (et) Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20071103